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Background: Delay in tuberculosis (TB) diagnosis may worsen the disease and increase TB transmission. Therefore,
timely diagnosis and treatment is critical in TB control. We aimed to assess the treatment delay of pulmonary TB
and its determinants in two Ugandan districts where TB infection control (TBIC) guidelines were formerly
implemented.
Methods: A facility based cross-sectional study was conducted in Mukono and Wakiso districts. Adult pulmonary TB
patients within three months of initiating treatment were included in the study. Delays were categorized into
unacceptable patient delay (more than 3 weeks from the onset of cough and the first consultation with a health
care provider), health service (more than one week from the first consultation to the initiation of TB treatment) and
total delay (more than 4 weeks since the onset of cough). The prevalences as well as predictors for the three delays
were determined.
Results: We enrolled 158 sputum positive patients. Unacceptable patient delay was noted in 91 (58%) patients, a
health service delay in 140 (88%) patients and a total delay in 140 (90%) patients. An independent predictor for
patient delay was male gender (p < 0.001). First visiting a non-public health facility (p = 0.001) was an independent
predictor of health service delay.
Conclusion: There is still a significant TB diagnosis and treatment delay in Uganda. Most of the delay was caused
by health system delay in the non-public health care sector. There is need for TB advocacy in the community,
training of health workers in TBIC and strengthening public-private partnerships in TB control.
Keywords: TB treatment delay, Patient delay, Health service delay, TB infection control, UgandaBackground
Uganda is among the 22 high tuberculosis (TB) burden
countries. It has a treatment success of 67%, default rate
of 11% and 50% of TB patients are HIV co-infected [1].
Multi-drug resistant TB (MDR-TB) poses a problem in
1.1% of new cases and 12% of retreatment cases in 2010
[1,2]. One of the contributors to these poor indicators is
due to the prolonged delay from the onset of TB disease
to the time of diagnosis and initiation of treatment.
Delay in diagnosis may lead to progression of disease, in-
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article, unless otherwise stated.[3,4]. Therefore, timely diagnosis and treatment is critical
in TB control. Studies from Uganda and Tanzania have
shown median diagnostic delays varying from 8 to 13
weeks [5-7]). In two systematic reviews, it was found that
diagnosis and treatment delays of TB occurs more often
in patients with smear negative TB, HIV infection, living
in a rural area and or far away from a health unit and in
patients consulting with traditional healers [8,9].
In 2009, WHO released TB infection control (TBIC)
guidelines [10]. Early detection and prompt effective TB
treatment are the hallmark of a successful TBIC. These
guidelines recommend minimizing the time spent in
health facilities, by ensuring that people with TB symp-
toms are rapidly identified and if found to have TB,
promptly treated. Exposure to people who are infectioustral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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patient visits [10]. Furthermore, encouraging people to
rapidly seek care if they have symptoms suggestive of
TB [10]. In 2008, the Uganda Ministry of Health
(MOH) in collaboration with the TB Union, through
support from the Tuberculosis Control Assistance
Programme implemented a two year TBIC project in
12 districts in Uganda including Mukono district. In
2010, the Ugandan MOH implemented TBIC in Wakiso
district and in 2011 released national TBIC guidelines,
adopted from the WHO [11]. To our knowledge no
other study in Uganda has examined TB treatment de-
lays since the implementation of TBIC. Our study
assessed the magnitude of patient, health service and
total delay; and their determinants in a predominantly
rural setting in Uganda.Methods
Design and study setting
A cross-sectional survey among patients with pulmonary
TB was conducted in Mukono and Wakiso districts.
These two central districts surrounding the capital
Kampala are partly semi-urban but predominantly rural
[12]. The reported case detection rates of new pulmon-
ary positive TB in Mukono and Wakiso districts were
40.1% and 38.5%, respectively in 2008. Mukono has 25
and Wakiso 26 healthcare facilities currently providing
TB services. The study was conducted among patients
attending selected health centre IV and hospital level fa-
cilities; government and one Private-Not-For Profit
(PNFPs) facilities. These facilities were purposely se-
lected because they handle most of the TB patients in
their geographical locations. In Uganda, TB services are
provided at health centre III (sub-county level) and
above. TB services are, at least in principle, free of
charge in all government facilities, while in PNFPs, pa-
tients pay for consultation and investigations, but after
diagnosis the TB drugs are provided for free. Diagnosis
of pulmonary TB is by smear microscopy. According to
TBIC guidelines, patients presenting to the facility with
cough of two or more weeks have to submit two sputum
samples in the form of a spot-sample and morning sam-
ple the following day. Spot specimens are collected on
the day the patient suspected to have TB is seen at the
facility, morning samples are collected early in the
morning of the second day [13]. A patient is diagnosed
with TB if one sputum smear is positive. Treatment
should be initiated on the same day after receipt of a
positive result, ideally within 24 hours after submission
of the first sputum specimen [11]. TB/HIV collaborative
activities exist in the study districts and so all HIV pa-
tients are supposed to be screened for TB and TB patients
counselled and tested for HIV.Study participant selection
We aimed to recruit patients 18 years and above, who
started treatment in the 3 months preceding the start of
the survey. Eligible participants were asked to participate
in the study as they visited the TB clinics for drug refill.
Patients were consecutively enrolled and interviewed
using a structured questionnaire. Patients previously
treated for TB and those with extra-pulmonary TB were
excluded from the study. Only sputum smear positive
patients were included in the study. All of them were
out-patients.
An interviewer-administered structured question-
naire was used, adapted from a previous study on TB
diagnosis delay conducted in public primary health fa-
cilities in Kampala city, Uganda [7]. The questionnaire
was translated to Luganda. The following information
was collected: demographic and socio-economic char-
acteristics, TB symptoms and duration in number of
weeks before seeking care outside home, the date of
patient’s first consultation with a health care provider
and any other consultations with subsequent pro-
viders, if any, before TB treatment was started, dis-
tance to the health facility where TB diagnosis was
made, and date of starting treatment. In addition pa-
tients were asked whether TB is curable and if they
had tested for HIV before being diagnosed of TB. Par-
ticipants were enrolled between December 2012 and
March 2013.
Definitions and measures
Patient delay was defined in a similar way as in previous
studies in Uganda, as the time interval in weeks be-
tween onset of cough and the first consultation with
any health care provider [5-7]. A health care provider
was defined as any person consulted by the patient
about his/her sickness who prescribed any form of
medication (Table 1). These included dispensers, phar-
macists, medical staff and herbalists/traditional healers.
Unacceptable patient delay was defined as a delay of
more than 3 weeks since the onset of cough (i.e. one
week after the 2 weeks of cough when one is considered
a TB suspect) [14,15]. Health service delay was defined
as the time in weeks from the first consultation to the
initiation of the TB treatment. Unacceptable health ser-
vice delay was defined as a delay of more than 1 week.
The total delay was the sum of both, patient and health
service delay [6,7]. Unacceptable total delay was defined
as a delay of more than 4 weeks [5,14]. Cough was
chosen to define delay because it is the cardinal symp-
tom of pulmonary TB. The estimated sample size of
158 patients was obtained assuming, from prior local
study that 91% would have a total delay of more than 4
weeks [5]. This took into consideration a power of 80%,
Table 1 Patient, health service and total delays in published studies and current study
Reference Definitions used Prevalence of
delay
Median/mean





- The time interval between
symptom onset and the first
medical consultation.
- The time taken from the first
medical consultation to when
the diagnosis was confirmed
and treatment started.












- A health provider was defined as
any person consulted by the
patient about his/her sickness, who
prescribed any form of medication.
These included dispensers,
pharmacists, medical staff and
herbalists or traditional healers.
- Total delay:
91%
- Health service delay was when
there was a delay of > 4 weeks
between the initial contact with
the health provider and the start
of TB treatment.
- Interval of > 2 weeks was




- The time interval between the day
of experiencing for the first time
one of the pulmonary symptoms
to the day the patient sought
medical advice for the first time.
- A time interval between first
consultations at a health facility
to the day the treatment was
initiated.
- The sum of the patient











- A time interval > 35
days.
- Interval of > 30 days was
considered as patient delay.
- A time interval of > 5 days was





- The time interval from the
appearance of the first symptoms
of tuberculosis until the first visit to
any formal health care facility
(health centres, hospitals or DOTS
centres).
- The time interval from the first
consultation at any formal
health facility until the date of
diagnosis.






- The time in weeks from the onset
of cough to a first consultation
with any health care provider.
- The time in weeks from the first
consultation to initiation of
treatment.
- Prolonged total delay
was defined as a delay










- Prolonged patient delay was
defined as a delay of > 8 weeks.
- Prolonged heath facility was






-The time interval in weeks between
onset of cough and the first
consultation with any health care
provider (dispensers, pharmacists,
medical staff and herbalists/
traditional healers).
-The time in weeks from the first
consultation to the initiation of
the TB treatment.
Unacceptable total delay













- Unacceptable health service
delay was defined as a delay of
more than 1 week.
- Unacceptable patient delay was
defined as a delay of more than 3
weeks since the onset of cough.
≠IQR = Interquartile range.
*SD = Standard deviation.
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ing and non response.
Quality control
The questionnaire used was pre-tested. Research assistants
were trained and supervised during data collection. Dur-
ation of symptoms, date of initiation of treatment werecounterchecked in the medical records. Data was double
entered into a computer, and the two copies of the data
verified.
Ethical considerations
The research protocol was approved by the institutional
review board of the Makerere University School of Public
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Technology (Ref.nr. HS 880). Permission from the in-
charges of the health facilities was obtained. Informed
written consent was obtained from the participants at the
time of data collection. Respondents were assured of
confidentiality.
Data management and analysis
Data were entered into Epi-info software version 6 and
exported to Stata software version 10 for analysis. Health
service delay (in days) was computed from the date of
first seeking care with cough symptom to when treat-
ment was initiated. It was later converted into weeks by
diving by 7. Descriptive statistics were computed, such
as frequency distributions, median and interquartile
ranges (IQRs). The normality of the delays was checked
using Shapiro test and were all found not be normally
distributed. Bivariate analysis using Chi-square test and
prevalence ratios (using generalized linear model with a
Poisson link) were performed. Multivariate analysis was
used to explore the predictors of the outcome variables
(patient, health service and total delay). Unacceptable
patient delay, health service delay and total delay were
compared for different sub-groups using prevalence ra-
tios and 95% CI. To identify factors independently asso-
ciated with unacceptable patient, health service and totalFigure 1 Flowchart showing the patients included in the analysis of tdelays, a multivariate analysis with delay time dichoto-
mized was performed. Possible predictors (age, sex, resi-
dence, type of health provider first visited, education
level and distance to the facility of diagnosis) were evalu-
ated in bivariate associations with each type of delay.
Variables associated with delays in the bivariate analysis
(p ≤ 0.2) were included in the model. Statistical signifi-
cance was taken as p < 0.05. We adjusted for the cluster-
ing effect at both bivariate and multivariate analysis.
Results
A total of 229 TB patients were prospectively enrolled
from 6 health facilities (3 hospitals and 3 health centre
IVs). Seventy one patients were excluded from further
analysis because they were sputum negative (59) and did
not have cough as one of their presenting symptoms
(12), leaving 158 patients (Figure 1). The median age
was 30 (IQR 25.5-38) years. Ninety six (61%) patients
were males, 78 (49%) were married and 13 (8%) had no
formal education, (Table 2). Patients’ median family size
was 4 (IQR3-7) and they were generally living in one liv-
ing room. More than half (102; 65%) of the patients lived
less than 60 minutes walking distance to the facility
where the TB was diagnosed. The majority of the pa-
tients, 104/157 (65%) had ever tested for HIV before TB
diagnosis (Table 2). One hundred forty three (97%)reatment delay in Mukono and Wakiso districts, Uganda.
Table 2 Socio-demographic and clinical characteristics of
the study patients
Variable Total n (%)
Sex (n = 158)
Female 62 (39)
Male 96 (61)





Monthly salary income in Ugandan shillings (n = 156)
≤20,000 39 (25)
> 20,000 117 (75)
Cost for one way journey to the facility
of diagnosis (n = 158)
≤2,000 104 (66)
>2,000 54 (34)




Residence (n = 158)
Rural 57 (36)
Semi-urban 101 (64)
Education level (n = 158)
No formal education 13 (8)
Primary 73 (46)
Secondary and above 72 (46)
Patient knows TB can be cured (n = 158)
Yes 82 (52)
No 76 (48)
Tested for HIV before TB diagnosis (n = 158)
Yes 104 (66)
No 54 (34)
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(45/143) reporting being HIV positive. In addition to
cough, at the time of diagnosis, patients had the follow-
ing symptoms: chest pain 94/157 (60%), fever 85/157
(54%), weight loss 80/157 (51%), loss of appetite 67/156
(43%) and haemoptysis 28/158 (18%).
Health care seeking behaviour
Only 35/158 (22%) patients first sought care from a pub-
lic health facility. Patients who first sought care from
non-public health facilities were similar to those who
first visited a public health facility regarding sex, marital
status, residence and having been tested for HIV beforeTB diagnosis. Patients of different age category and edu-
cation level tended to seek care differently. Non-public
health facilities were visited by 123 (78%) of the 158 pa-
tients: private clinics by 65 patients (41%), drug shops by
17 patients (11%), a private pharmacy by 16 patients
(10%), traditional healers/herbalists by 15 patients (9%)
and PNFPs by 10 patients (6%). Reasons for not seeking
care from public health facilities were available for 119
patients. These included: long waiting hours in 33/119
(28%), the facility being far away in 35/119 (29%), a bad
previous experience in 20/119 (17%) and thinking that
their illness was not that serious 31/119 (26%). Majority
of the respondents (143/158 (91%)), made the first con-
sultation because of cough. The services provided by the
health care provider during this first visit were: offering
non-TB medical treatment in 128/156 (82%) patients,
sputum examination in 24/156 (15%) patients, x-ray in
2/156 (1%) patients, and referring the remaining patients.
Delays and determinants
Patient delay
The median patient delay was 4 (IQR 2-8) weeks. In 91
respondents (58%) there was unacceptable patient delay.
The majority of the patients (81/91) who delayed seeking
care, thought that their symptoms would spontaneously
go away, while 11/91 (9%) did not perceive a time span
of more than 3 weeks as problematic. The remaining pa-
tients delayed to seek care due to economic constraints
and lack of family support. In our bivariate analysis, pa-
tient delay was significantly associated with being male
(p < 0.001), but not with age, education level, salary, dis-
tance to the facility of diagnosis, residence, marital status
or having tested for HIV before the current TB diagnosis
(Table 3). In our multivariate analysis, after controlling
for age, sex, education level, and marital status, male pa-
tients were more likely to delay seeking care (adjusted
Prevalence ratio [aPR] 1.61(1.43-1.82).
Health service delay
The median reported health system delay was 11 (5-24)
weeks. In the majority of the patients 140/158 (89%)
there was an unacceptable health service delay. The me-
dian number of visits to all sorts of health care providers
before being diagnosed was 3 (IQR3-9). Almost half of
the patients who delayed 60/140 (43%), lived beyond 5 km
from the facility where diagnosis was made (Table 4). In
our bivariate analysis, health service delay was significantly
associated with first seeking care in a non-public health fa-
cility (p < 0.001). In multivariate analysis, after controlling
for age, sex, distance to the facility of diagnosis, education
level and type of facility visited first, patients who first
sought care in the public health facility were significantly
less likely to have unacceptable health service delay, (aPR
0.62; 0.47-0.83).
Table 3 Predictors of unacceptable patient delay (>3 weeks)
Variable Unacceptable patient delay Univariate analysis Multivariate analysis P
Yes No Crude PR 95% CI Adjusted PR 95% CI
Sex
Female 26/62 (42) 36/62 (58) 1 1
Male 65/94 (69) 29/94 (31) 1.64 (1.41-1.91) 1.61 (1.43-1.82) <0.001*
Age group
15-34 52/100 (52) 48/100 (48) 1 1
35 & above 39/56 (70) 17/56 (30) 1.33 (0.98-1.82) 1.00 (0.85-1.18) 0.97
Education level
No formal education 9/13 (69) 4/13 (31) 1 1
Primary 49/72 (68) 23/72 (32) 0.98 (0.63-1.52) 0.92 (0.66-1.27) 0.61
Secondary & above 33/71 (46) 38/71 (54) 0.67 (0.42-1.06) 0.70 (0.45-1.09) 0.12
Income in Ugandan shillings
0-20,000 21/38 (55) 17/38 (45) 1 - -
>20,000 69/116 (59) 47/116 (59) 1.07 (0.85-1.34) - -
Distance to facility of diagnosis
Within 5km 48/85 (56) 37/85 (44) 1 - -
Over 5Km 43/71 (61) 28/71 (39) 1.07 (0.83-1.38) - -
Type of facility first visited
Non-Public(private) 69/122 (57) 53/122 (43) 1 - _
Public 22/34 (65) 12/34 (35) 1.14 (0.83-1.57)
Patient knows TB can be cured
No 48/81 (59) 33/81 (41) 1 - -
Yes 43/75 (57) 32/75 (43) 0.96 (0.86-1.08)
Tested for HIV before
Yes 59/102 (58) 43/102 (42) 1 _ _
No 32/54 (59) 22/54 (41) 1.02 (0.81-1.29)
Residence
Rural 35/57 (61) 22/57 (39) 1 _ _
Semi-urban 56/99 (57) 43/99 (43) 0.92 (0.68-1.23)
*Statistically significant.
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Data for total delay was available for only 154 patients.
The median total delay from onset of cough until start of
anti-TB treatment was 16 (9-30) weeks. In the majority of
the patients 140/154 (91%) there was an unacceptable
total delay. In a chi-square test unacceptable total delay
was significantly associated with first visiting a non-public
health facility (p = 0.05) (Table 5). Health service delay was
the greatest contributor (75%) to total delay. In our multi-
variate analysis being male and first seeking care from
non-public health facility were more likely to have un-
acceptable total delay, though not significant (Table 5).
Discussion
This study performed in two Ugandan districts highlights
the unacceptable delay from onset of cough to initiationof TB treatment. More than half of the patients delayed to
seek medical care in the presence of cough for more than
3 weeks. Health service delay was the biggest contributor
to the total delay. Patient delay was significantly associated
with being male. Health service delay was significantly as-
sociated with first seeking care from a non-public health
facility.
Three quarters of the total delay was due to health ser-
vice delay. This proportion of the total delay is similar to
what was found in a study among patients at the national
referral hospital in Kampala [5]. Sendagire et al., on the
other hand, in a study in Kampala City Councils clinics
observed that patient and health service delay equally con-
tributed to the delay [7]. The long health service delay in
our study shows that there are many missed chances for
TB diagnosis. While according to the Ugandan National
Table 4 Predictors of unacceptable health service delay (>1 week)
Variable Unacceptable health service delay Univariate analysis Multivariate analysis P
Yes No Crude PR 95% CI Adjusted PR 95% CI
Sex
Female 57/62 (92) 5/62 (8) 1 1
Male 83/96 (86) 13/96 (14) 0.94 (0.85-1.03) 0.98 (0.91-1.05) 0.63
Age group
<=34 92/101 (91) 9/101 (9) 1 1
>=35 48/57 (84) 9/57 (16) 0.92 (0.84-1.00) 1.02 (0.96-1.09) 0.44
Monthly income in Ugandan shillings
≤20,000 35/39 (90) 4/39 (10) 1 - -
>20,000 104/117 (89) 13/117 (11) 1.01 (0.93-1.09)
Education level
No formal education 10/13 (77) 3/13 (23) 1 1
Primary 63/73 (86) 10/73 (14) 1.12 (0.82-1.51) 0.99 (0.77-1.28) 0.99
Secondary and above 67/72 (93) 5/72 (7) 1.12 (0.92-1.57) 1.02 (0.80-1.30) 0.83
Marital status
Married 68/78 (87) 10/78 (13) 1 - -
Single 34/38 (89) 4/38 (11) 1.02 (0.90-1.16)
Separated/Widow/Divorce 38/42 (90) 4/42 (10) 1.03 (0.94-1.13)
Distance to facility of diagnosis
Within 5km 80/86 (93) 6/86 (7) 1 1
Over 5Km 60/72 (83) 12/72 (17) 0.89 (0.788-1.01) 0.93 (0.82-1.06) 0.29
Type of facility first visited
Non-Public (private) 119/123 (97) 4/123 (3) 1 1 0.001*
Public 21/35 (60) 14/35 (40) 0.62 (0.47-0.81) 0.62 (0.47-0.83)
Tested for HIV before
Yes 91/104 (88) 13/104 (13) 1 - -
No 49/54 (91) 5/54 (9) 1.03 (0.94-1.13)
Residence
Rural 50/57 (88) 7/57 (12) 1 _ _
Semi-urban 90/101 (89) 11/101 (11) 1.01 (0.89-1.15)
*Statistically significant.
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should be investigated for TB [11], in our study only 15%
of such patients had a sputum examination done on their
first visit to the health care provider. The unacceptable
health service delay is an indication of a weak performing
health system. This may be because of poor knowledge of
health workers about TB, resulting into a low index of
suspicion for TB, and/or lack of staff, infrastructure to
diagnose and treat TB. This long health service delay
means that a significant number of patients remain infec-
tious. This puts other patients in the health facilities and
health care workers (particularly HIV infected) at risk of
getting nosocomial TB, in addition to transmitting TB to
the household members. The finding of unacceptable
health service delay being associated with first seekingcare from non-public health facilities (non-TB health care
providers) is similar to what has been reported in other
studies [9,17]. Only public health facilities and a few pri-
vate providers provide TB treatment in Uganda [7]. There-
fore, non-public health facilities like pharmacies, drug
shops, some private clinics and traditional healers/herbal-
ist which do not regularly treat TB patients, may have a
lower index of suspicion for TB or even no knowledge at
all, compared to public facilities. Training of health
workers on new guidelines like the TBIC guidelines, are
mainly organized in public facilities. Thus seeking care
first with a private care provider results in delays in diag-
nosis and treatment of TB due the longer path from the
initial visit to finally accessing a TB service provider
(which is usually a public health facility) [17].
Table 5 Predictors of unacceptable total delay (>4 weeks)
Variable Unacceptable Total delay Univariate analysis Multivariate analysis
Yes No Crude PR 95% CI Adjusted PR 95% CI P
Sex
Female 53/61 (87) 8/61 (13) 1 1
Male 87/93 (94) 6/93 (6) 1.07 (0.96-1.20) 1.09 (0.99-1.20) 0.073
Age group
≤ 34 89/99 (90) 10/99 (10) 1 _ _
≥35 51/55 (93) 4/55 (7) 1.03 (0.94-1.12)
Salary income in Ugandan shillings
≤20,000 35/37 (95) 2/37 (5) 1 _ _
>20,000 104/115 (90) 11/115 (10) 0.95 (0.88-1.03)
Marital status
Married 68/75 (91) 7/75 (9) 1 _ _
Single 34/38 (89) 4/38 (11) 0.98 (0.92-1.05)
Separated/Widowed 38/41 (93) 3/41 (7) 1.02 (0.88-1.17)
Education level
No formal education 12/13 (92) 1/13 (8) 1 _ _
Primary 66/71 (93) 5/71 (7) 1.00 (0.90-1.12)
Secondary and above 62/70 (89) 8/70 (11) 0.95 (0.78-1.17)
Distance to facility of diagnosis
Within 5km 77/85 (91) 8/85 (9) 1 _ _
Over 5Km 63/69 (91) 6/69 (9) 1.00 (0.89-1.12)
Type of facility first visited
Non-Public (private) 112/120 (93) 8/120 (7) 1 1 _
Public 28/34 (82) 6/34 (18) 0.88 (0.74-1.05) 0.86 (0.74-1.01) 0.078
Tested for HIV before
Yes 91/104 (88) 13/104 (12) 1 - -
No 46/54 (91) 5/54 (9) 1.02 (0.91-1.15)
Residence
Rural 50/55 (91) 5/55 (9) 1 _ _
Semi-urban 90/99 (91) 9/99 (9) 1.00 (0.88-1.13)
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study is close to what was found in other studies from
Pakistan and Tanzania [18,19] though lower than what
was reported in Kampala City Councils clinics in Uganda
[7]. The longer total delay observed in our study com-
pared to previous studies conducted in Uganda [5,7] can
be explained by better access to health facilities in the
urban setting. Comparing treatment delay between differ-
ent studies is difficult because they often used different
definitions (Table 1). According to the WHO guidelines
and the Ugandan MOH TBIC guidelines, patients with
cough for 2 weeks and above should be investigated for
TB within 24 hours [10,11]. Therefore, in our study we
considered a delay of 3 weeks as unacceptable patient
delay and a delay of more than one week as unacceptable
health service delay. Adhering to these shorter delays willresult in low TB transmission and thus improved TB
control.
Almost half of the patients sought care within the first
three weeks of cough. This is lower than what was ob-
served in a national Ugandan referral hospital [5], where
70% of patients contacted a health care provider within
two weeks of cough. This could also be explained by bet-
ter access to health services in an urban setting, compared
to the rural setting where our study was conducted. Al-
most 10% of our patients first sought care from traditional
healers/herbalists. This is consistent with the findings in
South Africa [20]. This highlights the need to involve trad-
itional healers in TB control, since a substantial propor-
tion of patients seek care from them. The patient delay
observed in this study is comparable to those reported by
other studies in sub-Saharan Africa [5,7,21,22]. Patient
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This is contrary to what was observed in a study from
Tanzania where patient delay contributed to 90% of the
total delay [23]. However the Tanzanian study used the
following definition of patient delay “the period between
onset of symptoms and reporting to a health facility.” In
our study we defined patient delay as the period between
onset of symptoms and seeking care from any health care
provider. We used “any health care provider” because of
the WHO recommendation to involve all health care pro-
viders in TB control [2]. Patient delay was significantly as-
sociated with being male, unlike what was observed by
Mfinanga in Tanzania [24]. On the other hand, Johansson
et al. in Vietnam reported that men were more likely to
neglect symptoms and to seek care only when the disease
gets into an advanced stage [25]. This has also been re-
ported in HIV care, where men have been found to
present with advanced disease and were more likely to be
lost to follow-up [26,27].
Unacceptable health service and total delay were asso-
ciated with visiting non-public health facilities. To re-
duce these delays, coordination between the National
TB and Leprosy Programme (NTLP) and the private
sector is critical for TB control [2,28]. Efforts to engage
with private providers have already started in Uganda
and this resulted in improved case detection in an urban
setting [29]. But pharmacies, drug shops and traditional
healers need to be brought on board. This can be achieved
by the use of incentives to encourage private care pro-
viders to refer all TB suspects to a diagnostic facility [2].
However, there is a need to explore more sustainable ways
on how to involve them, more particularly the traditional
healers. A public-private mix in TB control is in line with
the Stop TB Strategy [2]. Furthermore, there is also a need
to train all health care providers to raise their level of sus-
picion for TB. In addition, community TB advocacy and
sensitization, which is advocated in TBIC is necessary to
improve TB awareness among the people and thus result
in early care seeking for TB symptoms. Rolling out rapid
diagnostics would also help in reducing diagnostic delay.
This could for instance be done by use of the gene X-pert
[2,30,31], but also by taking two spot sputum specimens
for smear microscopy on the same day rather than on dif-
ferent days [32], so as to reduce patients failing to return
in time or even being lost to follow up.
Our study has limitations. Being a retrospective study,
imprecise estimates of delay due to recall bias among
the patients could have influenced our results. This was
minimised by the use of TB treatment cards and case
notes. In addition, we asked patients if they thought TB
was curable, before they started on treatment. This
could have introduced a bias considering the health edu-
cation patients are given before they start and also in the
course of the treatment. We may have also introduced aselection bias by only including outpatients. The study
was carried out in a few facilities (health centre IVs and
hospitals) and mainly government, so this limits the
generalizability of our findings. The picture could be dif-
ferent in lower level facilities and in private facilities.
Last but not least, length of cough was used as an indi-
cator for patient delay. However, it can start in an insidi-
ous manner and so the timing of onset of cough can
vary among respondents depending on the manner they
gauge the seriousness of the symptom. Moreover, we did
not asses treatment delay of patients with smear negative
pulmonary TB and patients with extrapulmonary TB.
Conclusions
This study reveals that there is still a significant TB
treatment delay problem in Uganda. Our study under-
scores the need to involve all health care providers in TB
control. TB treatment delay can be seen as a proxy indica-
tor of health system performance. Our results point to the
fact that the public sector seems to be doing better than
the various private providers that operate in rural Uganda.
The range of relevant actions to be considered could include:
health education on TB and TBIC, further decentralization
of health services, appropriate training of health care pro-
viders in TBIC and public-private partnership in TB con-
trol. Research is needed on why there is prolonged health
service delay and how private care providers including
traditional healers can be effectively engaged by national
TB control programmes.
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